ScholarIQanswers from OpenAlex

Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke

PaperCitations, authors & open-access status

Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke have?

ScholarIQcitation count

Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke has 30 citations in the OpenAlex counts ScholarIQ stores.

When was Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke published?

ScholarIQyear

Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke has 2018 year in the ScholarIQ index.

What is the open-access status of Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke?

ScholarIQoa status

Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke has gold oa status in the ScholarIQ index.

What is the DOI of Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke?

ScholarIQdoi

The DOI for Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke is on the source record.

What is the PMID of Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke?

ScholarIQpmid

The PMID for Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke is on the source record.

What is the OpenAlex record for Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke?

ScholarIQopenalex

The OpenAlex for Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial